July 3, 2024

Aptamer Group signs agreement with AstraZeneca to explore Optimer delivery vehicles

Aptamer Group plc has partnered with AstraZeneca to evaluate Optimer® binders for targeted siRNA delivery to fibrotic liver cells, aiming to innovate gene therapies...

Baltic Classifieds Group Reports revenue grew 19% to €72.1 million, Full Year Results

Baltic Classifieds Group PLC (LON:BCG) reports solid growth with a 19% revenue increase to €72.1 million and a 20% rise in EBITDA for the year ending..

Syncona portfolio company Beacon Therapeutics raises $170 million in a Series B financing

Syncona Ltd (LON:SYNC) commits $42.5 million to Beacon Therapeutics' $170 million Series B financing to advance treatments for blinding retinal diseases...

GSK and CureVac to restructure collaboration into new licensing agreement

GSK plc and CureVac N.V. restructure their collaboration into a licensing agreement, enhancing mRNA vaccine development for influenza and COVID-19...

Invinity Energy Systems continued ‘substantial revenue growth’, says Alex Brooks, Canaccord (LON:IES)

Invinity Energy Systems plc (LON:IES), a leading manufacturer of vanadium flow batteries (VFBs), continues to make significant strides in the renewable energy sector. According to a..

Search

Funds

July 3, 2024

Aptamer Group signs agreement with AstraZeneca to explore Optimer delivery vehicles

Aptamer Group plc has partnered with AstraZeneca to evaluate Optimer® binders for targeted siRNA delivery to fibrotic liver cells, aiming to innovate gene therapies...

Baltic Classifieds Group Reports revenue grew 19% to €72.1 million, Full Year Results

Baltic Classifieds Group PLC (LON:BCG) reports solid growth with a 19% revenue increase to €72.1 million and a 20% rise in EBITDA for the year ending April 2024...

Syncona portfolio company Beacon Therapeutics raises $170 million in a Series B financing

Syncona Ltd (LON:SYNC) commits $42.5 million to Beacon Therapeutics' $170 million Series B financing to advance treatments for blinding retinal diseases...

GSK and CureVac to restructure collaboration into new licensing agreement

GSK plc and CureVac N.V. restructure their collaboration into a licensing agreement, enhancing mRNA vaccine development for influenza and COVID-19...
Search

Funds

July 3, 2024

FTSE 100

Funds